Today, Venture Global, Inc. (NYSE: VG) and Eni S.P.A. of Italy announced the execution of a new Sales and Purchase Agreement (SPA) for the purchase of 2 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from CP2 LNG, Venture Global’s third project, for 20 years. This deal marks Eni’s first ever long-term agreement with a U.S. LNG producer. To date, approximately 13.5 MTPA of CP2 Phase One has been sold, raising the total contracted capacity for all of Venture Global’s projects to 4...

Veranex, a global provider of product development and contract research services, today introduced the industry’s first Innovation CRO (iCRO)—an integrated development and research platform engineered to move medical devices and in-vitro diagnostics (IVDs) from concept to commercial success faster, with tighter budget control and a built-in path to payer adoption. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716366338/en/Verane...

Regula, a global developer of identity verification (IDV) solutions and forensic devices, has been recognized in the 2025 Gartner® Magic Quadrant™ for Identity Verification research. For the company, this recognition marks the outstanding capabilities of Regula’s IDV software and its ability to meet the current market needs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250827049906/en/Regula's solutions provides smooth and compreh...

Polpharma Biologics S.A. (“Polpharma Biologics”), specialized in the development and manufacturing of biosimilars, today announced that it has signed licensing agreements with MS Pharma, a leading biosimilar production and distribution company in the Middle East and North Africa (MENA) region, for the commercialization of its biosimilar candidates vedolizumab (PB016), ocrelizumab (PB018) and guselkumab (PB019) in the MENA region. Under the agreements, MS Pharma will be responsible for the reg...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Justin Gover to its Board of Directors, effective immediately. Mr. Gover brings more than 25 years of leadership in the biopharmaceutical industry to this role. As part of this Board transition, Dr. Linda McGoldrick will retire from her position on the Board at the end of October after more than 5 years of servi...

ITRS, a pioneer in real-time monitoring and observability for mission-critical industries, today announced its inclusion in the 2025 Gartner® Magic Quadrant™ for Observability Platforms. ITRS’s transformation into a unified observability platform, purpose-built for demanding and regulated IT environments, is the outcome of sustained investment in product innovation. By consolidating Geneos (application performance), Opsview (infrastructure monitoring), and Uptrends (digital experience monitor...

Hansen Technologies (ASX:HSN), a leading global provider of software and services to the communications & media and energy & utilities industries, has signed a three-year contract renewal with MultiChoice Group to enable the continued utilisation of Hansen CCB, as well as the extension of the existing managed services solutions. The agreement, initially for a term of three years, combines various contracts into a single master contract; aligning to MultiChoice’s ambition to transition...

TH Global Capital, an award-winning global boutique investment banking firm recognized as Boutique Investment Banking Firm of the Year by The M&A Advisor for three consecutive years, with a track record of closing transactions in 29 countries, is proud to announce the celebration of its 25th anniversary on July 24, 2025, marking a significant milestone in the firm’s journey. Founded in 2000 by Vivek Subramanyam, TH Global Capital has become a globally recognized leader in Tech Services, C...